“Hepatitis viruses can be passed through blood
transmission (such as by needles), through sexual contact, from
mother to unborn child or by cross contamination,” said Dr.
Hasbrouck. “Many people were infected years or decades ago, before
much was known about the viruses. If you are at risk, you should get
tested.”
Asian and Pacific Islanders are at higher risk for hepatitis B, but
most are unaware that they are infected. Individuals born, or whose
parents were born, in Asia or the Pacific Islands should talk with
their physician or health care provider about getting tested for
hepatitis B. The Center for Minority Health Services
is collaborating with five grantees (Asian Health Coalition, Asian
Human Services, Institute for Positive Living, Midwest Asian Health
Association, and Puerto Rican Cultural Center) to provide hepatitis
B outreach, awareness, and education to foreign born Asian and
African immigrant and refugee communities. Grantees are increasing
outreach and educational efforts that address an individual’s
hepatitis B risk, cultural and societal issues and co-factors that
result in disparities in screening and vaccination rates. In
addition, grantees are providing referrals and connections to
opportunities for screening, vaccination and treatment services.
Up to 75 percent of people with chronic hepatitis C
infection were born during 1945-1965 (baby boomers), most of whom
are unaware of their infection. As a result, they are not getting
treatment or making lifestyle changes to protect their health. These
individuals should get a blood test for hepatitis C. Also, anyone
who had a blood transfusion before July 1992 is also at risk and
should get tested.
Chronic viral hepatitis is considered to be a
“silent” disease because it progresses slowly and rarely causes
symptoms until decades after infection. By the time a person shows
symptoms, damage to the liver has already occurred. Viral hepatitis
is the leading cause of liver cancer and the most common reason for
liver transplants. Between 2008 and 2012, there were 9,316 reported
cases of chronic hepatitis B and 38,875 cases of chronic hepatitis C
reported to the IDPH.
[to top of second column] |
Effective treatments are available for hepatitis B and C. Advances
in hepatitis C treatments offer simpler dosing, shorter treatment
durations, fewer side effects, and, most importantly, higher cure
rates which eliminate the virus from the body and prevent liver
damage, cirrhosis and even liver cancer. There are vaccines
available for hepatitis A and hepatitis B to prevent these
infections. For additional information about viral hepatitis, visit:
http://www.cdc.gov/knowmorehepatitis/index.htm.
[Text by; SHELIA PORTER, ILLINOIS
DEPARTMENT OF PUBLIC HEALTH]
IDPH continues to implement its
Five Year Strategy 2014-2018 to maximize IDPH’s effectiveness,
influence and value for promoting wellness, health equity, safety
and improved health outcomes. Strategic plan priorities include
developing and expanding partnerships; improving data utilization;
reducing health disparities; improving regulatory compliance; and
branding, marketing and communicating IDPH’s value.
|